{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:31:01Z","timestamp":1769283061548,"version":"3.49.0"},"reference-count":32,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,1,24]]},"DOI":"10.1248\/bpb.b25-00334","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:09:06Z","timestamp":1769206146000},"page":"154-161","source":"Crossref","is-referenced-by-count":0,"title":["Role of Mitochondrial Protein, mitoNEET, in Impaired Intracellular Cholesterol Metabolism-Induced Neuronal Cell Death"],"prefix":"10.1248","volume":"49","author":[{"given":"Ayana","family":"Nakata","sequence":"first","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women\u2019s University, 11\u201368 Koshien Kyuban-cho, Nishinomiya, Hyogo 663\u20138179, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsugumi","family":"Takeo","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women\u2019s University, 11\u201368 Koshien Kyuban-cho, Nishinomiya, Hyogo 663\u20138179, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideya","family":"Mizuno","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women\u2019s University, 11\u201368 Koshien Kyuban-cho, Nishinomiya, Hyogo 663\u20138179, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Balestrino R, Schapira AHV. Parkinson disease. <i>Eur. J. Neurol.<\/i>, <b>27<\/b>, 27\u201342 (2020).","DOI":"10.1111\/ene.14108"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Thomas B, Beal MF. Parkinson\u2019s disease. <i>Hum. Mol. Genet.<\/i>, <b>16<\/b> (R2), R183\u2013R194 (2007).","DOI":"10.1093\/hmg\/ddm159"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Dinter E, Saridaki T, Diederichs L, Reichmann H, Falkenburger BH. Parkinson\u2019s disease and translational research. <i>Transl. Neurodegener.<\/i>, <b>9<\/b>, 43 (2020).","DOI":"10.1186\/s40035-020-00223-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ibarra-Guti\u00e9rrez MT, Serrano-Garc\u00eda N, Orozco-Ibarra M. Rotenone-induced model of Parkinson\u2019s disease: beyond mitochondrial complex I inhibition. <i>Mol. Neurobiol.<\/i>, <b>60<\/b>, 1929\u20131948 (2023).","DOI":"10.1007\/s12035-022-03193-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Alrouji M, Al-Kuraishy HM, Al-Mahammadawy AAA, Al-Gareeb AI, Saad HM, Batiha GE. The potential role of cholesterol in Parkinson\u2019s disease neuropathology: perpetrator or victim. <i>Neurol. Sci.<\/i>, <b>44<\/b>, 3781\u20133794 (2023).","DOI":"10.1007\/s10072-023-06926-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Shin KC, Ali Moussa HY, Park Y. Cholesterol imbalance and neurotransmission defects in neurodegeneration. <i>Exp. Mol. Med.<\/i>, <b>56<\/b>, 1685\u20131690 (2024).","DOI":"10.1038\/s12276-024-01273-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bar-On P, Crews L, Koob AO, Mizuno H, Adame A, Spencer B, Masliah E. Statins reduce neuronal \u03b1-synuclein aggregation in <i>in vitro<\/i> models of Parkinson\u2019s disease. <i>J. Neurochem.<\/i>, <b>105<\/b>, 1656\u20131667 (2008).","DOI":"10.1111\/j.1471-4159.2008.05254.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Colca JR, McDonald WG, Waldon DJ, Leone JW, Lull JM, Bannow CA, Lund ET, Mathews WR. Identification of a novel mitochondrial protein (\u201cmitoNEET\u201d) cross-linked specifically by a thiazolidinedione photoprobe. <i>Am. J. Physiol. Endocrinol. Metab.<\/i>, <b>286<\/b>, E252\u2013E260 (2004).","DOI":"10.1152\/ajpendo.00424.2003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Wiley SE, Murphy AN, Ross SA, van der Geer P, Dixon JE. MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>104<\/b>, 5318\u20135323 (2007).","DOI":"10.1073\/pnas.0701078104"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Golinelli-Cohen MP, Lescop E, Mons C, Gon\u00e7alves S, Cl\u00e9mancey M, Santolini J, Guittet E, Blondin G, Latour JM, Bouton C. Redox control of the human iron-sulfur repair protein MitoNEET activity <i>via<\/i> its iron-sulfur cluster. <i>J. Biol. Chem.<\/i>, <b>291<\/b>, 7583\u20137593 (2016).","DOI":"10.1074\/jbc.M115.711218"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lipper CH, Stofleth JT, Bai F, Sohn YS, Roy S, Mittler R, Nechushtai R, Onuchic JN, Jennings PA. Redox-dependent gating of VDAC by mitoNEET. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>116<\/b>, 19924\u201319929 (2019).","DOI":"10.1073\/pnas.1908271116"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wang Y, Landry AP, Ding H. The mitochondrial outer membrane protein mitoNEET is a redox enzyme catalyzing electron transfer from FMNH<sub>2<\/sub> to oxygen or ubiquinone. <i>J. Biol. Chem.<\/i>, <b>292<\/b>, 10061\u201310067 (2017).","DOI":"10.1074\/jbc.M117.789800"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kusminski CM, Holland WL, Sun K, Park J, Spurgin SB, Lin Y, Askew GR, Simcox JA, McClain DA, Li C, Scherer PE. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. <i>Nat. Med.<\/i>, <b>18<\/b>, 1539\u20131549 (2012).","DOI":"10.1038\/nm.2899"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Takahashi T, Yamamoto M, Amikura K, Kato K, Serizawa T, Serizawa K, Akazawa D, Aoki T, Kawai K, Ogasawara E, Hayashi J-I, Nakada K, Kainoh M. A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates mitochondrial function in db\/db mice. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>352<\/b>, 338\u2013345 (2015).","DOI":"10.1124\/jpet.114.220673"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kusminski CM, Chen S, Ye R, Sun K, Wang QA, Spurgin SB, Sanders PE, Brozinick JT, Geldenhuys WJ, Li W, Unger RH, Scherer PE. MitoNEET-Parkin effects in pancreatic \u03b1- and \u03b2-cells, cellular survival, and intrainsular cross talk. <i>Diabetes<\/i>, <b>65<\/b>, 1534\u20131555 (2016).","DOI":"10.2337\/db15-1323"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Furihata T, Takada S, Kakutani N, Maekawa S, Tsuda M, Matsumoto J, Mizushima W, Fukushima A, Yokota T, Enzan N, Matsushima S, Handa H, Fumoto Y, Nio-Kobayashi J, Iwanaga T, Tanaka S, Tsutsui H, Sabe H, Kinugawa S. Cardiac-specific loss of mitoNEET expression is linked with age-related heart failure. <i>Commun. Biol.<\/i>, <b>4<\/b>, 138 (2021).","DOI":"10.1038\/s42003-021-01675-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hu X, Jogasuria A, Wang J, Kim C, Han Y, Shen H, Wu J, You M. MitoNEET deficiency alleviates experimental alcoholic steatohepatitis in mice by stimulating endocrine adiponectin-Fgf15 axis. <i>J. Biol. Chem.<\/i>, <b>291<\/b>, 22482\u201322495 (2016).","DOI":"10.1074\/jbc.M116.737015"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bai F, Morcos F, Sohn YS, Darash-Yahana M, Rezende CO, Lipper CH, Paddock ML, Song L, Luo Y, Holt SH, Tamir S, Theodorakis EA, Jennings PA, Onuchic JN, Mittler R, Nechushtai R. The Fe-S cluster-containing NEET proteins mitoNEET and NAF-1 as chemotherapeutic targets in breast cancer. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>112<\/b>, 3698\u20133703 (2015).","DOI":"10.1073\/pnas.1502960112"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Geldenhuys WJ, Benkovic SA, Lin L, Yonutas HM, Crish SD, Sullivan PG, Darvesh AS, Brown CM, Richardson JR. MitoNEET (CISD1) knockout mice show signs of striatal mitochondrial dysfunction and a Parkinson\u2019s disease phenotype. <i>ACS Chem. Neurosci.<\/i>, <b>8<\/b>, 2759\u20132765 (2017).","DOI":"10.1021\/acschemneuro.7b00287"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. <i>Neuron<\/i>, <b>39<\/b>, 889\u2013909 (2003).","DOI":"10.1016\/S0896-6273(03)00568-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Takeo T, Miyake M, Mizuno H. Neuroprotective effects of probucol against rotenone-induced toxicity <i>via<\/i> suppression of reactive oxygen species production in SH-SY5Y cells. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 1154\u20131162 (2024).","DOI":"10.1248\/bpb.b24-00099"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Roca-Agujetas V, Barbero-Camps E, de Dios C, Podlesniy P, Abadin X, Morales A, Mar\u00ed M, Trull\u00e0s R, Colell A. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer\u2019s disease. <i>Mol. Neurodegener.<\/i>, <b>16<\/b>, 15 (2021).","DOI":"10.1186\/s13024-021-00435-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dietschy JM, Turley SD. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. <i>J. Lipid Res.<\/i>, <b>45<\/b>, 1375\u20131397 (2004).","DOI":"10.1194\/jlr.R400004-JLR200"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Barber CN, Raben DM. Lipid metabolism crosstalk in the brain: glia and neurons. <i>Front. Cell. Neurosci.<\/i>, <b>13<\/b>, 212 (2019).","DOI":"10.3389\/fncel.2019.00212"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nanjundaiah S, Chidambaram H, Chandrashekar M, Chinnathambi S. Role of microglia in regulating cholesterol and tau pathology in Alzheimer\u2019s disease. <i>Cell. Mol. Neurobiol.<\/i>, <b>41<\/b>, 651\u2013668 (2021).","DOI":"10.1007\/s10571-020-00883-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Subczynski WK, Pasenkiewicz-Gierula M, Widomska J, Mainali L, Raguz M. High cholesterol\/low cholesterol: effects in biological membranes: a review. <i>Cell Biochem. Biophys.<\/i>, <b>75<\/b>, 369\u2013385 (2017).","DOI":"10.1007\/s12013-017-0792-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Rosa P, Fratangeli A. Cholesterol and synaptic vesicle exocytosis. <i>Commun. Integr. Biol.<\/i>, <b>3<\/b>, 352\u2013353 (2010).","DOI":"10.4161\/cib.3.4.11831"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. <i>Nature<\/i>, <b>438<\/b>, 612\u2013621 (2005).","DOI":"10.1038\/nature04399"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Liu WW, Todd S, Coulson DTR, Irvine GB, Passmore AP, McGuinness B, McConville M, Craig D, Johnston JA. A novel reciprocal and biphasic relationship between membrane cholesterol and \u03b2-secretase activity in SH-SY5Y cells and in human platelets. <i>J. Neurochem.<\/i>, <b>108<\/b>, 341\u2013349 (2009).","DOI":"10.1111\/j.1471-4159.2008.05753.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jakubec M, Bari\u00e5s E, Furse S, Govasli ML, George V, Turcu D, Iashchishyn IA, Morozova-Roche LA, Halskau \u00d8. Cholesterol-containing lipid nanodiscs promote an \u03b1-synuclein binding mode that accelerates oligomerization. <i>FEBS J.<\/i>, <b>288<\/b>, 1887\u20131905 (2021).","DOI":"10.1111\/febs.15551"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Giordano S, Lee J, Darley-Usmar VM, Zhang J. Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death. <i>PLOS ONE<\/i>, <b>7<\/b>, e44610 (2012).","DOI":"10.1371\/journal.pone.0044610"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Callizot N, Combes M, Henriques A, Poindron P. Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. <i>PLOS ONE<\/i>, <b>14<\/b>, e0215277 (2019).","DOI":"10.1371\/journal.pone.0215277"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00334\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:28:47Z","timestamp":1769225327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00334\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00334","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"article-number":"b25-00334"}}